Allergic bronchopulmonary aspergillosis

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 5, 2002, Pages 685-692

  Greenberger, Paul A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Aspergillosis; Aspergillus fumigatus; Bronchiectasis; End stage; Eosinophils; IgE antibody; Lymphocytes; Prednisone; Sinusitis

Indexed keywords

ANTIFUNGAL AGENT; CD4 ANTIGEN; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E; ITRACONAZOLE; PLACEBO; PREDNISONE;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHOPULMONARY ASPERGILLOMA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; HUMAN; LABORATORY TEST; LUNG FUNCTION TEST; LUNG LAVAGE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; THORAX RADIOGRAPHY; TREATMENT INDICATION;

EID: 0036858609     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.130179     Document Type: Article

References (73)

1. Patterson R, Golbert T. Hypersensitivity disease of the lung. Univ Michigan Med Center J 1968;34:8-11.
2. Slavin RG, Laird TS, Cherry JD. Allergic bronchopulmonary aspergillosis in a child. J Pediatr 1970;76:416-21.
3. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis: A review and report of eight new cases. Thorax 1952;7:317-33.
4. Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 1988;81:646-50.
5. Schwartz HJ, Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 1991;117:138-42.
6. Becker JW, Burke W, McDonald G, et al. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 1996;109:1536-40.
7. Skov M, Pressler T, Jensen HE, et al. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999;54:44-50.
8. Geller DE, Kaplowitz H, Light MJ, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Reported prevalence, regional distribution, and patient characteristics. Chest 1999;116:639-46.
9. Zeaske R, Bruns WT, Fink JN, et al. Immune responses to Aspergillus in cystic fibrosis. J Allergy Clin Immunol 1988;82:73-7.
10. Mitchell-Heggs P, Mearns M, Batten JC. Cystic fibrosis in adolescents and asthma. Q J Med 1976;45:479-504.
11. Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 1979;120:863-73.
12. Laufer P, Fink JN, Bruns T, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984;73:44-8.
13. Feanny S, Forsyth S, Corey M, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: A secretory immune response to a colonizing organism. Ann Allergy 1988;60:64-8.
14. Light MJ, Greene LM, Wilson NW, et al. Increase in allergic bronchopulmonary aspergillosis in CF patients in San Diego. Pediatr Pulmonol 1991;6(suppl):276.
15. Baculard A, Scalbert A, Tassin E, et al. A prospective study of Aspergillus fumigatus (Af) allergy and/or Af bronchopulmonary infection in children with cystic fibrosis [abstract]. Pediatr Pulmonol 1994;10(suppl):257.
16. Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994;105:32-6.
17. Marchant JR, Warner JO, Bush A. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 1994;49:1002-5.
18. FitzSimmons SC. Cystic Fibrosis Foundation. Patient Registry. 1995 Annual Data Report. Bethesda (MD): The Foundation; 1996.
19. Skov M, Koch C, Reimert CM, et al. Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Allergy 2000;55:50-8.
20. Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Role of atopy and response to itraconazole. Chest 1999;115:364-70.
21. Wojnarowski C, Eichler I, Gartner C, et al. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med 1997;155:1902-7.
22. deShazo RD, Chapin K, Swain RE. Fungal sinusitis. N Engl J Med 1997;337:254-9.
23. Sher TH, Schwartz HJ. Allergic Aspergillus sinusitis with concurrent allergic bronchopulmonary Aspergillus: Report of a case. J Allergy Clin Immunol 1988;81:844-6.
24. Eppinger TM, Greenberger PA, White DA, et al. Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Allergy Clin Immunol 1999;104:1265-72.
25. Greenberger PA, Miller TP, Roberts M, et al. Allergic bronchopulmonary aspergillosis in patients with and without bronchiectasis. Ann Allergy 1993;70:333-8.
26. Proceedings of the Cystic Fibrosis Foundation ABPA Consensus Conference; 2001 Jun 12-13; Bethesda, Md.
27. Backman KS, Zull D, Patterson R. Diagnostic complexity in a patient with asthma, pulmonary infiltrates, and eosinophilia. Clinical allergy-immunology rounds. Ann Allergy Asthma Immunol 1995;75:391-400.
28. Mastella G, Rainisio M, Harms HK. et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur Respir J 2000;16:464-71.
29. Glancy JJ, Elder JL, McAleer R. Allergic bronchopulmonary fungal disease without clinical asthma. Thorax 1981;36:345-9.
30. Patterson R, Greenberger PA, Lee TM. et al. Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1987;80:663-8.
31. Katzenstein A-L A. Immunologic lung disease. In: Katzenstein A-L A, editor, Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease, 3rd Edition. Philadelphia: WB Saunders; 1997. p. 138-67.
32. Kuhn RA, Javer AR. Allergic fungal sinusitis: A four-year follow-up. Am J Rhinol 2000;14:149-56.
33. Greenberger PA. Allergic funsal sinusitis. In: Patterson R, Greenberger PA, Roberts ML, editors. Allergic Bronchopulmonary Aspergillosis. Providence (RI): Oceanside Publications; 1995. p. 53-6.
34. Latge J-P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12:310-50.
35. Radin RC, Greenberger PA, Patterson R, et al. Mold counts and exacerbations of allergic bronchopulmonary aspergillosis. Clin Allergy 1983;13:271-5.
36. McCarthy DS, Pepys J. Allergic bronchopulmonary aspergillosis: Clinical immunology 2: Skin, nasal and bronchial tests. Clin Allergy 1971;1:415-32.
37. Patterson R, Greenberger PA, Radin RC, et al. Allergic bronchopulmonary aspergillosis: Staging as an aid to management. Ann Intern Med 1982;96:286-91.
38. Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1984;74:68-71.
39. Lee TM, Greenberger PA, Patterson R, et al. Stage V (fibrotic) allergic bronchopulmonary aspergillosis: A review of 17 cases followed from diagnosis. Arch Intern Med 1987;147:319-23.
40. Neeld DA, Goodman LR, Gurney JW, et al. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1990;142:1200-5.
41. Ward S, Heyneman L, Lee MJ, et al. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 1999;173:937-42.
42. Eaton T, Garrett J, Milne D, et al. Allergic bronchopulmonary aspergillosis in the asthma clinic: A prospective evaluation of CT in the diagnostic algorithm. Chest 2000;118:66-72.
43. Mitchell TAM, Hamilos DL, Lynch DA, et al. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis (ABPA). J Asthma 2000;37:65-72.
44. Banerjee B, Greenberger PA, Fink JN, et al. Molecular characterization of Aspergillus fumigatus allergens. Indian J Chest Dis Allied Sci 2000;42:239-48.
45. Hemmann S, Ismail C, Blaser K, et al. Skin-test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus. Clin Exp Allergy 1998;28:860-7.
46. Allergen Nomenclature Sub-Committee, International Union of Immunological Societies. Available at: http://www.allergen.org. Accessed September 30, 2002.
47. Rathore VB, Johnson B, Fink JN, et al. T cell proliferation and cytokine secretion to T cell epitopes of Asp f 2 in ABPA patients. Clin Immunol 2001;100:228-35.
48. Murali PS, Kurup VP, Bansal NK, et al. IgE downregulation and cytokine induction by Aspergillus antigens in human allergic bronchopulmonary aspergillosis. J Lab Clin Med 1998;131:228-35.
49. Chauhan B, Santiago L, Kirschmann DA, et al. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 1997;159:4072-6.
50. Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000;106:723-9.
51. Greenberger PA, Grammer LC, Goulsby C. Lymphocyte activation during and after exacerbations of allergic bronchopulmonary aspergillosis [abstract]. Clinical Res 1994;42:385A.
52. Brown JE, Greenberger PA, Yarnold PR. Soluble serum interleukin-2 receptors in patients with asthma and allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 1995;74:484-8.
53. Khan S, McClellan JS, Knutsen AP. Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis. Int Arch Allergy Immunol 2000;123:319-26.
54. Greenberger PA, Liotta JL, Roberts M. The effects of age on isotypic antibody responses to Aspergillus fumigatus: Implications regarding in vitro measurements. J Lab Clin Med 1989;114:278-84.
55. Apter AJ, Greenberger PA, Liotta JL, et al. Fluctuations of serum IgA and its subclasses in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1989;84:367-72.
56. Patterson R, Rosenberg M, Roberts M. Evidence that Aspergillus fumigatus growing in the airway of man can be a potent stimulus of specific and nonspecific IgE formation. Am J Med 1977;63:257-62.
57. Greenberger PA, Smith LJ, Hsu CCS, et al. Analysis of bronchoalveolar lavage in allergic bronchopulmonary aspergillosis: Divergent responses of antigen specific antibodies and total IgE. J Allergy Clin Immunol 1988;82:164-70.
58. Kurup VP, Banerjee B, Hemmann S, et al. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 2000;30:988-93.
59. Miller PW, Hamosh A, Macek M Jr, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996;59:45-51.
60. Marchand E, Verellen-Dumoulin C, Mairesse M, et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001;119:762-7.
61. Greenberger PA. Allergic bronchopulmonary aspergillosis. In: Grammer LC, Greenberger PA, editors. Patterson's Allergic Diseases. 6th Ed. Philadelphia: Lippincott, Williams & Wilkins; 2002. p. 529-54.
62. Knutsen AP, Mueller KR, Levine AD, et al. Asp f 1 CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1994;94:215-21.
63. Cockrill BA, Hales CA. Allergic bronchopulmonary aspergillosis. Annu Rev Med 1999;50:303-16.
64. Patterson R, Greenberger PA, Harris KE. Allergic bronchopulmonary aspergillosis. Chest 2000;118:7-8.
65. Tomee JF, Kauffman HF, Klimp AH, et al. Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in Aspergillus-related diseases. J Allergy Clin Immunol 1994;93:768-78.
66. Schuyler M. The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. J Lab Clin Med 1998;131:194-6.
67. Bosken CH, Myers JL, Greenherger PA, et al. Pathologic findings of allergic bronchopulmonary aspergilllosis. Am J Surg Pathol 1988;12:216-22.
68. Safirstein BH, D'Souza MF, Simon G, et al. Five-year follow-up of allergic bronchopulmonary aspergillosis. Ann Rev Respir Dis 1973;108:450-9.
69. Leon EE, Craig TJ. Antifungals in the treatment of allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 1999;82:511-7.
70. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Cllin Infect Dis 2000;30:696-709.
71. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 2001;4:CD001108.
72. Salez F, Brichet A, Desurmont S, et al. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999;116:1665-8.
73. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-62.